Nobuo Kubota

1.5k total citations
74 papers, 1.2k citations indexed

About

Nobuo Kubota is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Biochemistry. According to data from OpenAlex, Nobuo Kubota has authored 74 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 15 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Biochemistry. Recurrent topics in Nobuo Kubota's work include DNA Repair Mechanisms (14 papers), Effects of Radiation Exposure (12 papers) and Amino Acid Enzymes and Metabolism (10 papers). Nobuo Kubota is often cited by papers focused on DNA Repair Mechanisms (14 papers), Effects of Radiation Exposure (12 papers) and Amino Acid Enzymes and Metabolism (10 papers). Nobuo Kubota collaborates with scholars based in Japan, United States and Russia. Nobuo Kubota's co-authors include Ryuichi Okayasu, Masato Inazu, Yoshitaka Matsumoto, Yuji Kiuchi, Dong Yu, Ryoichi Hirayama, Tetsuo Inada, Kazutoshi Shibuya, Katsuji Oguchi and Soichiro Torigoe and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Nobuo Kubota

74 papers receiving 1.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Nobuo Kubota 664 186 168 135 134 74 1.2k
Ke‐He Ruan 733 1.1× 146 0.8× 110 0.7× 84 0.6× 100 0.7× 79 1.4k
S T Smiley 951 1.4× 121 0.7× 194 1.2× 53 0.4× 115 0.9× 12 1.8k
W. Bret Church 852 1.3× 136 0.7× 436 2.6× 111 0.8× 80 0.6× 72 1.8k
Julie A. Zorn 947 1.4× 163 0.9× 265 1.6× 69 0.5× 226 1.7× 21 1.5k
Ursula Egner 1.1k 1.7× 121 0.7× 205 1.2× 224 1.7× 140 1.0× 37 1.8k
Melanie Schroeder 1.8k 2.7× 82 0.4× 147 0.9× 95 0.7× 106 0.8× 37 3.0k
Huayun Deng 1.0k 1.5× 74 0.4× 163 1.0× 57 0.4× 56 0.4× 43 1.5k
Stefani N. Thomas 1.4k 2.1× 96 0.5× 192 1.1× 57 0.4× 72 0.5× 61 2.1k
Silvia Mari 848 1.3× 116 0.6× 86 0.5× 41 0.3× 217 1.6× 28 1.4k
Vladimir A. Mitkevich 1.5k 2.3× 91 0.5× 168 1.0× 59 0.4× 72 0.5× 190 2.2k

Countries citing papers authored by Nobuo Kubota

Since Specialization
Citations

This map shows the geographic impact of Nobuo Kubota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuo Kubota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuo Kubota more than expected).

Fields of papers citing papers by Nobuo Kubota

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuo Kubota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuo Kubota. The network helps show where Nobuo Kubota may publish in the future.

Co-authorship network of co-authors of Nobuo Kubota

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuo Kubota. A scholar is included among the top collaborators of Nobuo Kubota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuo Kubota. Nobuo Kubota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Inazu, Masato, Tomoko Yamada, Nobuo Kubota, & Tsuyoshi Yamanaka. (2013). Functional expression of choline transporter-like protein 1 (CTL1) in small cell lung carcinoma cells: A target molecule for lung cancer therapy. Pharmacological Research. 76. 119–131. 38 indexed citations
2.
Kubota, Nobuo & Yoshitaka Matsumoto. (2012). Hsp90 Inhibitors are Promising Radiosensitizers for Radiotherapy. 28(4). 53–62. 1 indexed citations
3.
Shikano, Naoto, Masato Ogura, Jun‐ichi Sagara, et al.. (2010). Radioiodinated 4-iodo-l-meta-tyrosine, a system L selective artificial amino acid: molecular design and transport characterization in Chinese hamster ovary cells (CHO-K1 cells). Nuclear Medicine and Biology. 37(8). 903–910. 4 indexed citations
4.
Shikano, Naoto, Masato Ogura, Hiroyuki Okudaira, et al.. (2009). Uptake of 3-[125I]iodo-α-methyl-l-tyrosine into colon cancer DLD-1 cells: characterization and inhibitory effect of natural amino acids and amino acid-like drugs. Nuclear Medicine and Biology. 37(2). 197–204. 9 indexed citations
5.
Noguchi, Miho, Dong Yu, Ryoichi Hirayama, et al.. (2006). Inhibition of homologous recombination repair in irradiated tumor cells pretreated with Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin. Biochemical and Biophysical Research Communications. 351(3). 658–663. 104 indexed citations
7.
Matsumoto, Yoshitaka, et al.. (2005). Preferential Sensitization of Tumor Cells to Radiation by Heat Shock Protein 90 Inhibitor Geldanamycin. Journal of Radiation Research. 46(2). 215–221. 31 indexed citations
9.
Shikano, Naoto, Keiichi Kawai, Akiko Kubodera, et al.. (2004). Transcellular transport of 4-iodo-L-meta-tyrosine via system L across monolayers of kidney epithelial cell line LLC-PK1. Nuclear Medicine and Biology. 31(4). 477–482. 3 indexed citations
10.
Matsumoto, Yoshitaka, et al.. (2003). Geldanamycin, an inhibitor of Hsp90, sensitizes human tumour cells to radiation. International Journal of Radiation Biology. 79(12). 973–980. 63 indexed citations
11.
Kimura, Makoto, Tomoko Masuda, Kôji Yamada, et al.. (2002). Novel diphenylalkyl piperazine derivatives with dual calcium antagonistic and antioxidative activities. Bioorganic & Medicinal Chemistry Letters. 12(15). 1947–1950. 30 indexed citations
12.
Kubota, Nobuo, S Okada, Tomohiro Inada, Ken Ohnishi, & Takeo Ohnishi. (2000). Wortmannin sensitizes human glioblastoma cell lines carrying mutant and wild type TP53 gene to radiation. Cancer Letters. 161(2). 141–147. 26 indexed citations
13.
Kubota, Nobuo, et al.. (1999). Mutation Induction and RBE of Low Energy Neutrons in V79 Cells.. Journal of Radiation Research. 40(Suppl.). 21–27. 8 indexed citations
14.
Inazu, Masato, et al.. (1999). Pharmacological characterization of dopamine transport in cultured rat astrocytes. Life Sciences. 64(24). 2239–2245. 44 indexed citations
16.
Omura, Motoko, Soichiro Torigoe, Hiroaki Kurihara, Sho Matsubara, & Nobuo Kubota. (1998). Comparison between Fractionated High Dose Rate Irradiation and Continuous Low Dose Rate Irradiation in Spheroids. Acta Oncologica. 37(7-8). 681–686. 9 indexed citations
17.
Omura, Motoko, Soichiro Torigoe, & Nobuo Kubota. (1997). SN-38, a metabolite of the camptothecin derivative CPT-11, potentiates the cytotoxic effect of radiation in human colon adenocarcinoma cells grown as spheroids. Radiotherapy and Oncology. 43(2). 197–201. 40 indexed citations
18.
Kodama, Daisuke, et al.. (1996). High Pressure Vapor-Liquid Equilibria and Density Behaviors for Carbon Dioxide+Methanol System at 313.15 K.. Netsu Bussei. 10(1). 16–20. 28 indexed citations
19.
Komatsu, Kenshi, Yutaka Okumura, Nobuo Kubota, & Michael R. Lieber. (1994). The scid factor on human chromosome 8 restores both V(D)J recombination and double-strand break repair. Journal of Radiation Research. 35(4). 268. 2 indexed citations
20.
Kubota, Nobuo, C.K. Hill, & M. M. Elkind. (1989). Fixation and repair of radiation-induced potentially mutagenic damage sensitive to hypertonic treatment in human diploid fibroblasts. Mutation Research/Environmental Mutagenesis and Related Subjects. 216(2). 137–143. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026